1. Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire 
Anne Sirvent, Nathalie Dhedin, Mauricette Michallet, Nicolas Mounier, Catherine Faucher, Ibrahim Yakoub-Agha, Mohamad Mohty, Marie Robin, Reza Tabrizi, Laurence Clement, Karin Bilger, Fabrice Larosa, Nathalie Contentin, Anne Huyn, Sylvie François, Claude- Eric Bulabois, Patrice Ceballos, Jean-Henri Bourrhis, Agnès Buzyn, Jérôme Cornillon, Gaelle Guillerm, Thierry de Revel, Jacques-Olivier Bay, François Guilhot, Noël Milpied 
Biology of Blood and Marrow Transplantation 
Volume 16, Issue 1, Pages (January 2010)
DOI: /j.bbmt
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Overall survival (OS) and progression-free survival (PFS) of the study population (n=68).
Biology of Blood and Marrow Transplantation  , 78-85DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Overall survival (OS) and progression-free survival (PFS) according to status of disease at transplantation. CR, complete remission group (n=32); PR/SD/PD, partial remission/stable disease/progressive disease group (n=36).
Biology of Blood and Marrow Transplantation  , 78-85DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Cumulative incidence of nonrelapse mortality (NRM) and relapse.
Biology of Blood and Marrow Transplantation  , 78-85DOI: ( /j.bbmt )
Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions